Clin2
NCT07118813Possibly a fitRecruiting

AI predicts kidney cancer surgery outcomes

Renal Cell Carcinoma (Kidney Cancer)

Part of Cancer, Kidney & urinary, Women’s health & pregnancy clinical trials.

This trial uses artificial intelligence to read CT scans and predict how well kidney cancer patients will do after surgery. It aims to help doctors plan better treatment for you.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
400 people
Ages
18 years and older
Study type
Observational

Who can take part

  • You have kidney cancer (renal cell carcinoma) and are having surgery at Wuhan Union Hospital between August 2025 and August 2026.
  • You are over 18 years old.
  • You had at least one CT scan of your belly before treatment.
  • Your kidney cancer was confirmed by a tissue biopsy.
  • You do not have another active cancer, and your medical records are complete.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07059936Recruiting
AI and scans to predict immunotherapy response in liver cancer

This study uses artificial intelligence (AI) to analyze your CT or MRI scans and help predict how well immunotherapy might work for your liver cancer. The goal is to find better ways to match you with the right treatment and improve your outcomes.

Wuhan, Hubei
NCT07639567Not yet recruiting
AI screening for early cancer detection on routine chest-abdomen-pelvis CT

This study tests whether artificial intelligence (AI) can help doctors spot early signs of cancer (breast, liver, kidney, or bladder) on routine CT scans that patients get for other reasons. The goal is to see if this 'opportunistic screening' catches cancers earlier when they may be easier to treat.

Wuhan, Hubei
NCT07059923Recruiting
Predicting immunotherapy response in lung cancer with AI and radiology

This study uses artificial intelligence and CT scan analysis to predict how well lung cancer patients will respond to immunotherapy. It may help doctors choose the best treatment for you.

Wuhan, Hubei
NCT07304492Not yet recruiting
AI for Kidney Tumors Using Regular CT Scans

This trial uses artificial intelligence (AI) to analyze standard, non-contrast CT scans to identify and understand kidney tumors. It aims to help doctors make better decisions without needing special dye injections.

Shanghai, Shanghai Municipality
NCT06714916Recruiting
AI-guided kidney tumor surgery study

This study uses artificial intelligence to help plan the best surgery for kidney tumors. You may be eligible if you have a kidney tumor that can be removed with surgery and have had a special CT scan within the past month.

Nanjing, Jiangsu
NCT07166445Recruiting
Using AI to read kidney cancer CT scans for better staging

This study uses a computer program (deep learning) to look at your kidney CT scan and tell if your cancer is more advanced (stage T3) or earlier (stage T1-T2). The goal is to help doctors plan the best treatment for you.

Beijing

Hear when a new Renal Cell Carcinoma (Kidney Cancer) trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.